Who are Zushima plaster with low dose's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Qi-Zheng-Xiao-Tong Plaster.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/zushima-plaster-with-low-dose.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Zushima plaster with low dose — Competitive Intelligence Brief

Zushima plaster with low dose (Zushima plaster with low dose) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine herbal plaster. Area: Pain Management / Musculoskeletal.

marketed Traditional Chinese medicine herbal plaster Pain Management / Musculoskeletal Small molecule Live · refreshed every 30 min

Target snapshot

Zushima plaster with low dose (Zushima plaster with low dose) — Guang'anmen Hospital of China Academy of Chinese Medical Sciences. Zushima plaster delivers traditional Chinese medicine ingredients transdermally to provide pain relief and anti-inflammatory effects.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Zushima plaster with low dose TARGET	Zushima plaster with low dose	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	marketed	Traditional Chinese medicine herbal plaster
Qi-Zheng-Xiao-Tong Plaster	Qi-Zheng-Xiao-Tong Plaster	Shanghai University of Traditional Chinese Medicine	phase 3	Traditional Chinese medicine herbal plaster

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine herbal plaster class)

Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
Shanghai University of Traditional Chinese Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Zushima plaster with low dose — Competitive Intelligence Brief. https://druglandscape.com/ci/zushima-plaster-with-low-dose. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab